期刊文献+

深低温保存同种肺动脉在复杂先天性心脏病治疗中的应用 被引量:1

Clinical application of cryopreserved pulmonary homograft conduits in complex congenital heart diseases
原文传递
导出
摘要 目的探讨深低温保存同种肺动脉治疗复杂先天性心脏病的疗效。方法应用深低温保存同种肺动脉治疗复杂先天性心脏病25例。术前诊断:法洛四联症12例,肺动脉闭锁合并室间隔缺损6例,大动脉转位合并室间隔缺损和肺动脉瓣狭窄3例,右心室双出口合并室间隔缺损和肺动脉瓣狭窄2例,先天性主动脉瓣狭窄2例。结果24例手术顺利完成,1例手术中死亡,术后院内死亡1例。其余23例均痊愈出院。随访6~60个月,无远期死亡,23例患者生活质量良好。复查超声心动图示植入的同种肺动脉无明显钙化、衰败。结论深低温保存的同种肺动脉应用于复杂先天性心脏病矫治,具有良好的早、中期效果。 Objective To study the clinical outcomes of cryopreserved pulmonary homograft conduits in the treatment of complex congenital heart disease(CHD). Methods Twenty-five patients with complex CHD received cryopreserved pulmonary homograft conduits transplantation. There were 12 cases with Tetralogy of Fallot, 6 cases with pulmonary atresia complicated by ventricular septal defect, and 3 cases with transposition of the great arteries complicated by ventricular septal defect and pulmonary stenosis , 2 cases with double outlet right ventricle complicated by ventricular septal defect and pulmonary stenosis, 2 cases with congenital aortic valve stenosis. Results Twenty-four patients completed the surgery. One case died of extracorporeal circulation after heart resuscitation during surgery and another one died of low cardiac output syndrome soon after surgery. The other 23 cases recovered and discharged from hospital. The patients were follow-up for 6 to 60 months, which showed good life quality without death case. Echocardiography showed no obvious calcification or degeneration in the implanted pulmonary homograft conduits. Conclusion Cryopreserved pulmonary homograft conduits have good early and midterm effectiveness in the treatment of complex congenital heart diseases.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第3期256-257,共2页 Jiangsu Medical Journal
关键词 先天性心脏病 同种肺动脉 Congenital heart disease Pulmonary homograft
  • 相关文献

参考文献7

  • 1Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years[J]. Eur J Cardiothorac Surg,2007,32(1): 133-142.
  • 2Karamlou T, Ungerleider RM, Alsotrli B, et ak Oversizing pulmonary homograft conduits does not significantly decrease allograft failure in children[J]. Eur J Cardiothorac Surg, 2005,27(4):548-553.
  • 3Dignan R,O'Brien M, Hogan P, et al. Influence of HLA matching and associated factors on aortic valve homograft function [J]. J Heart Valve Dis,2000,9(4) :504-511.
  • 4Baskett RJ,Nanton MA,Warren AE,et al. Human leukocyte antigerrDR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions[J]. J ThoracCardiovasc Surg,2003,126(1) :232-239.
  • 5Hogan PG,O'Brien MF. Improving the allograft: does the immune response matter [J ] ? J Thorac Cardiovasc Surg, 2003, 126 ( 5 ) : 1251-1253.
  • 6Mevns B, Jashari R, Gewillig M, et al.Factors influencing the survival of cryopreserved homograft. The second homograft performs as well as the first[J]. Eur J Cardiothorac Surg, 2005,28 (2):211- 216.
  • 7Levine AJ,Miller PA, Stumper OS, et al. Early results of fight ventricular-pulmonary artery conduits in patients under 1 year of age [J]. Eur J Cardiothorac Surg, 2001,19(2) :122-126.

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部